Dr. Munish Gairola

MBBS. MD, DNB

Director Radiation Oncology

Book an Appointment

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

Rajiv Gandhi Cancer Institute, Mahender Kumar Jain Marg, Niti Bagh, New Delhi, Delhi 110049

About

Dr. Munish Gairola , MD DNB Radiation Oncology with over 23 yrs. of experience in the field of oncology. He completed his MBBS from G.S.V.M. Medical College, Kanpur, MD from Kanpur University and subsequently worked in Post Graduate Institute of Medical Education & Research (PGIMER) Chandigarh and All India Institute of Medical Sciences (AIIMS), New Delhi for several years.

He worked in Christie’s Hospital, Manchester, UK as clinical fellow and IMRT Fellow at Memorial Sloan Kettering Cancer Centre (MSKCC) New York, USA. He has also received UICC fellowship for National Defence Medical College (NDMC) Saitama, Japan. Dr. Gairola has published many articles in various International and National Journals. Presently Dr Munish Gairola is working as Director Radiation Oncology at Rajiv Gandhi Cancer Institute & Research Centre (RGCI & RC), Delhi.

Specialized Areas

Head & Neck Cancer – High conformal techniques viz IMRT, IGRT, Adaptive Radiotherapy, Brachytherapy
CNS Cancers- High Precision techniques viz Steriotactic Radiotherapy(SRT), Stereotactic Radiosurgery (SRS)
Paediatric Cancers
Lung Cancer – Steretactic Body Radiotherapy (SBRT), Sterotactic Ablative Body Radiotherapy (SABR), Image Guided Radiotherapy (IGRT)

Educational Background

IMRT Fellow, Memorial Sloan Kettering Cancer Centre(MSKCC), NY, USA
Clinical Research Fellow, Chirstie Hospital, Manchester, UK
DNB (Radiation Oncology) , National Board of Examination, New Delhi, India
MD (Radiation Oncology) J K Cancer Institute ,GSVM Medical College, Kanpur, India
MBBS, GSVM Medical College, Kanpur, UP, India

Experience

1990- 1993 – JUNIOR RESIDENT (Resident Teaching Fellow) To Radiotherapy, J.K. Cancer Institute and G.S.V.M. Medical College Kanpur
1993- 1994 – SENIOR REGISTRAR in Department Of Radiotherapy and Oncology Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh
1995 – 1999 – SENIOR RESIDENT In the Department of Radiotherapy, All India Institute of Medical Sciences (AIIMS), New Delhi
1999- 2002 – RESEARCH OFFICER in IAEA Project of Multi-Institutional Trial on Altered Fractionation of Radiation Therapy (5# Vs 6#) In Head and Neck Cancers. (Chief Co-Coordinator- Prof Jens Overgaard- Danish Cancer Institute)
1993- 1993 – CLINICAL RESEARCH FELLOW At Christie’s Hospital Manchester, U.K.
2004- 2004 – CLINICAL OBSERVER for IMRT in Head & Neck and Brain tumours at Memorial Sloan Kettering Cancer Centre (MSKCC), New York, USA

Professional Journey

Awards

Received Medical Excellence Award -2014 for valuable Contribution in radiation Oncology
Travel Fellowship to Attend ESTRO-EORTC Meeting at Brussels, Belgium on Radiation for Benign Disease by Department Of Science and Technology (DST), India
Travel Fellowship to Attend International Congress of Radiation Oncologists (ICRO-2001) Held at Melbourne, Australia by Ministry Of Human Resource & Development (HRD), India
Travel Grant to Attend International Congress of Radiation Oncologist (ICRO-2001) held at Melbourne, Australia by International Society of Radiation Oncologist (ISRO)
UICC Fellowship (UICC-ICRETT) awarded to Visit National Defence Medical College, Saitama, Japan
Grant from UICC & Norwegian Cancer Society Grant to Attend 18th UICC Congress held At Oslo, Norway June /July 2003.
Travel Fellowship to attend 18th UICC Congress Held at Oslo, Norway June /July 2003 by Department Of Science And Technology (DST), India

Publication

CHAPTERS IN TEXT BOOK

Comparison of therapy outcomes between 2-dimensional radiotherapy and IMRT for early glottic cancer. ESTRO 2021
Is it too early to recommend local treatment in oligometastatic NSCLC: a plea for equipoise 10.1093/bjr/tqae068. British Journal of Oncology 2024
Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study. 10.1186/s40959-024-00225-1. Cardio-oncology 2024
Role of neoadjuvant therapy in resectable pancreatic carcinoma: a review article
Survival Outcomes in Different Sino-nasal Malignancies: An Institutional Review. 10.1177/25898892241232746. Journal of Current Oncology 2024
Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer. 10.1007/s12105-024-01614-9. Head and Neck Pathology 2024
Time saved is time earned: Implementation of an agile workflow system in a high-volume radiation oncology centre Workflow optimization in radiation oncology. 10.21203/rs.3.rs-4015333/v1. Preprint
Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: Update 2022. Cancer Research Statistics and Treatment 2024
Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022. Cancer Research Statistics and Treatment 2024
Introduction to Indian clinical practice consensus guidelines for the management of squamous cell carcinoma the head-and-neck: Update 2022. Cancer Research Statistics and Treatment 2024
Indian clinical practice consensus guidelines for the management of hypopharyngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
Indian clinical practice consensus guidelines for the management of oropharyngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
Effectiveness of Head-and-Neck Molecular Imaging Reporting and Data System Criterion in Head-and-Neck Squamous Cell Carcinoma PostConcurrent Chemoradiotherapy. Indian Journal of Nuclear Medicine 2023
A practical and practicable framework for implementing cardiac-sparing radiotherapy techniques in breast cancer. Cancer Research Statistics and Treatment 2023
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort. The British journal of radiology 2023
Risk-Adapted Target Delineation for Breast Cancer: Controversies and Considerations. Practical Radiation Oncology 2022
To Study the Impact of Different Optimization Methods on Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy Plans for Hip Prosthesis Patients. Journal of Medical Physics. 2022
Virtual Training on IGRT: A Unique Initiative of a Private Cancer Center from a Developing Country with Regional Academic Collaboration during COVID-19 Pandemic. International Journal of Radiation Oncology*Biology*Physics 2022
Immunotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC) After Progression on Chemotherapy: Real-World Results from a Prospective Institutional Cohort. Immunotherapy 2022
Combined Diagnostic Accuracy of Diffusion and Perfusion MR Imaging to Differentiate Radiation-Induced Necrosis from Recurrence in Glioblastoma. Diagnostics 2022
Depth of Invasion as an Independent Predictor of Survival in Patients of Stage III Squamous Cell Carcinoma of the Oral Tongue. The Laryngoscope 2021
Indian clinical practice consensus guidelines for the management of nasopharyngeal Indian J Cancer. 2020 Feb;57(Supplement):S9–11.
Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment Oral Oncol. 2020;96:89–96.
Indian clinical practice consensus guidelines for the management of oral cavity Indian J Cancer. 2020 Feb;57(Supplement):S6–8.
Indian clinical practice consensus guidelines for the management of oropharyngeal Indian J Cancer. 2020 Feb;57(Supplement):S12–5
Indian clinical practice consensus guidelines for the management of laryngeal Indian J Cancer. 2020 Feb;57(Supplement):S19–21.
Indian clinical practice consensus guidelines for the management of very advanced disease of squamous cell carcinoma of head and Indian J Cancer. 2020 Feb;57(Supplement):S22–5.
Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and Indian J Cancer. 2020 Feb;57(Supplement):S1–5.
Pseudoprogression on 68Ga- Prostate-Specific Membrane Antigen-11 PET/CT in a Treated Clin Nucl Med. 2020 Aug;45(8):621–2.
Impact of acuros XB algorithm in deep-inspiration breath-hold (DIBH) respiratory techniques used for the treatment of left breast Rep Pract Oncol Radiother. 2020 Aug;25(4):507–14.
Malignant esophagorespiratory fistulas: a comparative effectiveness survival BMJ Support Palliat Care. 2020 Aug 21
Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Clin Nucl Med. 2020 Mar;45(3):204–5.
A case report evaluating combined effect of intensity-modulated radiotherapy and deep inspiratory breath-hold for mediastinal lymphoma: A dosimetric Lung India. 2020 Feb;37(1):57–62.
Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy
“Radiation Recall Phenomenon” with Novel Cytotoxic Agents: An Emerging Trend in the Last Decade. Indian Journal of Medical and Paediatric Oncology 42(2021;42:28-34) May 2021
Role of Functional Imaging in evaluation of Radiation Colitis. Radiation and Oncology 2020
Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy. Accepted in Indian Journal of Cancer
Inter-correlation between various high risk pathological risk factors in squamous cell carcinoma tongue. ESTRO 2021
Pre-treatment hemoglobin as a surrogate marker for survival in head and neck squamous cell carcinoma. ESTRO 2021
Survival outcomes comparison between simultaneous integrated boost IMRT and sequential IMTRT in head and neck cancer. ESTRO 2021
Tumour volume as a prognostic factor for recurrent head and neck cancers treated with re-irradiation. ESTRO 2021
Comparison between two-dose levels versus three-dose levels in IMRT in head and neck cancers. ESTRO 2021
Impact of anterior commissure involvement in early glottic cancer treated with radical IMRT. ESTRO 2021
Dosimetric impact of tumour regression in carcinoma cervix treated with radical IMRT. ESTRO 2021
Impact of human papilloma virus on treatment outcomes in oropharyngeal cancer in India. ESTRO 2021
Simultaneous integrated boost IMRT versus sequential IMRT in head and neck cancers. ESTRO 2021
Wide histological spectrum of sinonasal malignancies and survival outcomes – An institutional review. ESTRO 2021
Cancers of Head and Neck. In Gaura K Rath, Bidhu K Mohanti (Eds) Text Book of Radiation Oncology- Principles and Practice. B I Churchill Livingston Pp 131-199.
Paediatric Oncology. In Gaura K Rath, Bidhu K Mohanti (Eds) Text Book of Radiation Oncology- Principles and Practice. B I Churchill Livingston Pp 669-720.
Radiotherapy in Juvenile Angiofibroma
Role Of Radiotherapy In Cranipharyngioma
Brachytherapy In Soft Tissue Sarcoma
Stereotaxy In Pituitary Adenoma
Radiotherapy in Kaposi Sarcoma
Radiotherapy in Age Related Macular Degeneration
Intravaginal Brachytherapy by Ovoids to Control Vaginal Bleeding In Cervical Cancers. Should The Haemostatic Dose Be Disregarded ?
Organ Preservation In Muscle Invasive Bladder Tumor
Brachytherapy Alone or in Combination with External Beam Radiation in the Postoperative Management of Stage I & II Endometrial Carcinoma
Palliative Care Education And Training During Residency: A Survey Among Residents at A Tertiary Care Hospital
Medical Disorders Associated with Endometrial Cancer
Primary Spinal Epidural Ewing’s Sarcoma: Report of 5 Cases and Review Of Literature
Brachytherapy In Lung Cancer
Late Reaction In Normal Tissue Following External Beam Radiotherapy In Carcinoma Cervix: An Overview
External Beam Radiotherapy and Thyroid Disorders